BPC-157 50mg — Vial Spec, Reconstitution Math & COA

Overview of BPC-157 50mg Vials in High-Throughput Research

A 50mg vial of BPC-157 (Body Protection Compound 157, a synthetic pentadecapeptide derived from human gastric juice protein fragments) supplies a high-concentration lyophilized cake intended for extensive laboratory assay workflows. In preclinical environments where researchers run continuous dose-response curves, cell culture assays, or multi-week rodent tissue injury protocols, standard 5mg or 10mg single-use vials require constant reconstitution and lot-switching, introducing micro-variations into experimental datasets.

Utilizing a single 50mg research mass allows laboratories to reconstitute a single, uniform stock solution. This minimizes inter-vial variance across expansive testing groups. However, handling larger peptide masses demands strict analytical oversight, precise volumetric calculations, and deliberate aliquot partitioning to prevent degradation from repeated thermal cycling.

PX1 Catalog Availability & High-Volume Sourcing Notice

PX1 Research maintains a rigorous catalog of analytical-grade research peptides. Depending on ongoing inventory cycles, PX1 supplies standard research units such as single-dose standard vials alongside specialized bulk orders. Researchers seeking immediate fulfillment for standard experimental designs can access our primary catalog via bpc-157 5mg/10mg options or browse our comprehensive research peptide index.

If your experimental protocol specifically mandates a 50mg single-vial mass format for liquid handler integration or specific bulk formulation steps, PX1 provides custom fill solutions and institutional sourcing through our dedicated bulk lab account services. Every lot—regardless of fill mass—undergoes identical analytical verification prior to release.

Biological Mechanisms Evaluated in Preclinical Literature

BPC-157 is primarily categorized as a tissue repair research peptide. Preclinical literature demonstrates that the peptide interacts with the focal adhesion kinase (FAK) and paxillin pathways, stimulating accelerated cellular migration and organization at injury sites. In rodent models, researchers observe that BPC-157 promotes robust angiogenesis—the formation of new blood vessels—by upregulating vascular endothelial growth factor (VEGF) expression and activating the VEGFR2 signaling cascade.

In vitro assays and animal models demonstrate that BPC-157 is studied for accelerated repair of tendon, ligament, muscle, and gut lining. Unlike direct mitogenic agents that induce unguided cellular proliferation, BPC-157 appears to orchestrate structural matrix remodeling. Observations in mucosal injury models indicate that the compound counteracts NSAID-induced gastrointestinal damage by modulating nitric oxide (NO) synthase expression and maintaining endothelial structural integrity under oxidative stress.

Reconstitution Mathematics for 50mg Lyophilized Mass

Reconstituting a 50mg peptide cake requires careful consideration of final target concentrations, solvent volume limits, and fluid displacement. Because a 50mg solid mass contributes negligible displacement volume upon dissolution, added diluent volumes dictate total liquid concentration directly.

Below are the calculated concentrations based on common lab solvent additions using bacteriostatic water or sterile saline (0.9% NaCl):

• 1.0 mL Diluent Volume = 50.0 mg/mL concentration (50,000 µg/mL). Recommended strictly for stock concentrate storage or automated micro-dispensing. • 2.0 mL Diluent Volume = 25.0 mg/mL concentration (25,000 µg/mL). Provides a manageable working concentration for micro-pipetting. • 3.0 mL Diluent Volume = 16.67 mg/mL concentration (16,667 µg/mL). Offers balanced fluid volume for mid-sized serial dilution series. • 5.0 mL Diluent Volume = 10.0 mg/mL concentration (10,000 µg/mL). Standard working stock for general in vitro cellular delivery setups.

To verify exact microliter-to-microgram conversions based on customized volumetric inputs, researchers should utilize our interactive reconstitution calculator.

Aliquot Planning and Solution Stability Protocols

Once reconstituted, peptide stock solutions in liquid phase suffer progressive hydrolysis and peptide aggregation if stored improperly. For a 50mg reconstituted mass, leaving the primary vial in liquid state at 4°C for extended periods risk steady potency decline.

To maximize structural integrity, laboratories must execute an aliquot protocol immediately following complete dissolution:

1. Reconstitute the 50mg cake under sterile laminar flow using pre-chilled diluent. 2. Divide the primary stock into single-use micro-centrifuge tubes (e.g., 50 µL to 200 µL aliquots) matching daily assay requirements. 3. Snap-freeze the sub-aliquots using liquid nitrogen or a dry ice/ethanol bath. 4. Store working aliquots at -20°C or -80°C until needed.

Avoid freeze-thaw cycles. Each thermal transition destabilizes the peptide backbone, leading to fragment formation that skews experimental results.

Analytical Certificate of Analysis (COA) Standards

Every batch of BPC-157 distributed by PX1 Research undergoes multi-point analytical verification at an independent ISO 17025 accredited laboratory. High-capacity formats like 50mg require explicit quality control to ensure total mass purity and uniformity across the fill.

Our published certificate of analysis hub documents verified parameters for every batch:

• Purity Verification via High-Performance Liquid Chromatography (HPLC): Guarantees chemical purity meeting or exceeding 99.0%, showing clear baseline separation with minimal synthesis side-products. • Identity Confirmation via Mass Spectrometry (MS): Confirms exact molecular weight (1419.53 Da) matching the theoretical pentadecapeptide sequence. • Bacterial Endotoxin Testing: Assayed via Limulus Amebocyte Lysate (LAL) testing to ensure levels remain strictly below standard preclinical thresholds (< 0.05 EU/mg), preventing confounding inflammatory artifacts in cell assays.

PX1 ships every order with lot-matched COAs linked directly to the physical vial label.

Comparative Analysis: BPC-157 vs. Other Tissue Repair Peptides

When designing tissue repair and cellular migration experiments, researchers frequently compare BPC-157 against related regenerative compounds. While BPC-157 focuses primarily on angiogenic VEGF upregulation and local extracellular matrix organization, TB-500 (Thymosin Beta-4 sequence derivative) operates by sequestering G-actin to drive actin polymerization and systemic cellular mobility. In contrast, copper-binding peptides like GHK-Cu regulate collagen synthesis and gene expression in dermal modeling, while growth hormone secretagogues like CJC-1295 stimulate systemic endocrine cascades to alter metabolic repair parameters.

Evaluating these compounds side-by-side in vitro helps elucidate whether tissue-localized angiogenic signaling (BPC-157) or cytoskeletal remodeling (TB-500) yields higher structural resolution in targeted repair assays. Comprehensive compound descriptions are indexed within our general research library.

Decision Matrix: Selecting 50mg Bulk vs. Standard 5mg/10mg Vials

Determining whether to acquire a 50mg large-format vial or multiple 5mg/10mg standard vials depends on experimental design and infrastructure:

• Select 50mg Vials When: Running automated high-throughput assays, continuous robotic liquid handling, long-term multi-arm rodent studies requiring identical stock solution, or custom formulation work where inter-vial variance must be eliminated entirely. • Select Standard 5mg/10mg Vials When: Conducting low-volume exploratory assays, short-duration pilot studies, or protocols with infrequent dosing intervals where aliquots would remain frozen beyond recommended shelf life.

For standard workflow setups, utilizing 5mg or 10mg vials reduces the risk of solution loss due to accidental contamination during pipetting.

PX1 Manufacturing Quality Standards & Laboratory Shipping

PX1 Research operates within USA-based GMP-compliant facilities to ensure absolute consistency across all lyophilized research compounds. Our synthesis protocols utilize solid-phase peptide synthesis (SPPS) followed by rigorous purification and vacuum freeze-drying.

To preserve peptide integrity during transport, orders are dispatched same-day (Monday through Friday) from our centralized distribution facilities in California and Arizona. Lyophilized cakes demonstrate superior thermal stability at ambient temperatures during transit, but immediate cold-chain storage at -20°C upon receipt is required for long-term sample preservation.